Topic

Articles

EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.

Industry Forced to Rethink Patient Participation in Trials

Eliminating barriers to engage underrepresented populations.

Importance of Diversity in Parkinson’s Research

Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.

Real-World Evidence Studies can Enhance Diversity and Equity in Clinical Research

Recognizing pre-pandemic pain points, such as patient engagement and protocol development, could lead to post-pandemic trial success. 

Addressing the Needs of Clinical Trial Sites in a Post-COVID-19 World

Evaluating the lessons learned about trial sites from COVID-19 to form new strategies and improve patient safety for the future.

Shifting Perspectives on Site Networks to Create Positive Change

With the assistance of mobile research nursing, in-home visits provide solid alternative to trial participants, especially during COVID-19.

When Trials Stumble, Mobile Research Nursing Lends a Helping Hand

Jody Casey of Elligo Health Research gives insight into the issue of diversity in trials and what needs to be done to correct it.

COVID-19 Highlights Need for More Diversity in Trials

Practical suggestions for identifying what actionable insights have been impactful on clinical studies. 

How to Measure Your Patient-Centric Impact

The pandemic has thus far disproportionally impacted minority populations, and our ongoing failure to adequately represent all patients regardless of demographic background has never been more important to remedy than it is today, writes ACRP Workforce Innovation Officer Beth Harper. 

The Time is Now to Promote Clinical Trial Workforce Diversity

Beyond technology, awareness, and access—cultural competence is key.

Diversity in Clinical Trials: Path to Achieving Health Equity

Past decades have shown gender-based differences in clinical trial results are often overlooked when considering safety and effectiveness.  

Gender Bias in the Clinical Evaluation of Drugs

This article highlights how C2N Diagnostics and Firma Clinical Research teamed up to create a successful Alzheimer's diagnostic clinical trial while allowing participants to remain in their homes.

Key Points to Success in Decentralized Alzheimer’s Diagnostic Clinical Trial

How integrated data platforms can help find the best-suited patients for cancer studies and reduce the burden on care teams.

Busting Patient Recruitment Bottlenecks in Oncology Trials

Case study focused on quest for potential Parkinson’s biomarker highlights opportunities and challenges in site selection.

The Importance of Site Selection

Recruitment study tests the use of a ride-sharing service.

Overcoming Transportation Barriers to Trial Participation

Exploring the Institute for Neurodegenerative Disorders’ non-traditional approach to engaging community physicians.

Building a Physician Referral Network: A Case Study

President of Commercial Solutions at Syneos Health, Michelle Keefe, writes how the industry must take an additional step beyond explaining and predicting customer behavior, and employ evidence-based strategies to change their behavior by helping customers make well-informed decisions.

Achieving Insight-Driven Care: Rely on Data and Behavioral Science to Unlock Real Change

A case study of a Parkinson’s disease trial demonstrates how one study team met its enrollment goals.

Developing an Effective Multimodal Recruitment Plan

Kenneth Getz is a senior research fellow at the Tufts Center for the Study of Drug Development.

Tracking the evolution and effectiveness of CISCRP’s clinical research awareness and literacy campaigns.  

New Models to Raise Public and Patient Awareness

First column in this series looks at the effectiveness of digital marketing as an outreach tool.